Onkure Therapeutics, Stock Retained Earnings
| OKUR Stock | 8.38 0.33 4.10% |
OnKure Therapeutics, fundamentals help investors to digest information that contributes to OnKure Therapeutics,'s financial success or failures. It also enables traders to predict the movement of OnKure Stock. The fundamental analysis module provides a way to measure OnKure Therapeutics,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to OnKure Therapeutics, stock.
| Last Reported | Projected for Next Year | ||
| Retained Earnings | -102.1 M | -107.2 M |
OnKure |
OnKure Therapeutics, Company Retained Earnings Analysis
OnKure Therapeutics,'s Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
More About Retained Earnings | All Equity Analysis
Retained Earnings | = | Beginning RE + Income | - | Dividends |
Current OnKure Therapeutics, Retained Earnings | (102.05 M) |
Most of OnKure Therapeutics,'s fundamental indicators, such as Retained Earnings, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OnKure Therapeutics, is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
OnKure Retained Earnings Driver Correlations
Understanding the fundamental principles of building solid financial models for OnKure Therapeutics, is extremely important. It helps to project a fair market value of OnKure Stock properly, considering its historical fundamentals such as Retained Earnings. Since OnKure Therapeutics,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of OnKure Therapeutics,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of OnKure Therapeutics,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Retained Earnings shows how the firm utilizes its profits over time. In simple terms, investors can think of retained earnings as the amount of profit the company has reinvested in the business since its inceptions. However the methodology to make a decision over how much profit to retain is different between companies in different industries. For example, growing industries tend to retain more of their earnings than more matured industries as they need more assets investment to sustain their growth.
| Competition |
Based on the latest financial disclosure, OnKure Therapeutics, has a Retained Earnings of (102.05 Million). This is 110.96% lower than that of the Healthcare sector and 205.32% lower than that of the Biotechnology industry. The retained earnings for all United States stocks is 101.09% higher than that of the company.
OnKure Retained Earnings Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OnKure Therapeutics,'s direct or indirect competition against its Retained Earnings to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OnKure Therapeutics, could also be used in its relative valuation, which is a method of valuing OnKure Therapeutics, by comparing valuation metrics of similar companies.OnKure Therapeutics, is currently under evaluation in retained earnings category among its peers.
OnKure Fundamentals
| Net Income | (35.31 M) | ||||
| Total Debt | 137.58 M | ||||
| Total Asset | 35.73 M | ||||
| Retained Earnings | (102.05 M) | ||||
| Working Capital | 26.48 M | ||||
| Net Asset | 35.73 M |
About OnKure Therapeutics, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OnKure Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OnKure Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OnKure Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with OnKure Therapeutics,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OnKure Therapeutics, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OnKure Therapeutics, will appreciate offsetting losses from the drop in the long position's value.Moving against OnKure Stock
| 0.76 | EVLO | Evelo Biosciences | PairCorr |
| 0.72 | VAXX | Vaxxinity | PairCorr |
| 0.67 | FBIOP | Fortress Biotech Pref | PairCorr |
| 0.66 | FRTX | Fresh Tracks Therapeutics | PairCorr |
| 0.59 | EPRX | Eupraxia Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to OnKure Therapeutics, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OnKure Therapeutics, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OnKure Therapeutics, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OnKure Therapeutics, to buy it.
The correlation of OnKure Therapeutics, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OnKure Therapeutics, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OnKure Therapeutics, moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OnKure Therapeutics, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for OnKure Stock Analysis
When running OnKure Therapeutics,'s price analysis, check to measure OnKure Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OnKure Therapeutics, is operating at the current time. Most of OnKure Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of OnKure Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OnKure Therapeutics,'s price. Additionally, you may evaluate how the addition of OnKure Therapeutics, to your portfolios can decrease your overall portfolio volatility.